| 常用名 | 曲格列汀 | CAS号 | 865759-25-7 |
|---|---|---|---|
| 价格 | ¥需询单/1kg ¥需询单/1g | 纯度 | 98.0% |
| 备货期 | 3天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Trelagliptin(SYR-472) is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D). IC50 value:Target: DPP4Two Phase II clinical studies have been completed with Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus. Phase III clinical studies with trelagliptin in Japan to evaluate its safety and efficacy in a once-weekly oral treatment regimen. Currently, all available DPP-4 inhibitors are dosed once-daily. A once-weekly treatment, such as trelagliptin, would provide patients with a convenient treatment alternative and has the potential to improve treatment compliance. 作用: 曲格列汀化学名为2-[{6-[(3R)-3-氨基哌啶-1-基]-3-甲基-2,4-二氧代-3,4-二氢嘧啶-1(2H)-基}甲基]-4-氟苄腈,由日本武田药品工业株式会社开发的一种有效的二肽基肽酶IV(DPP-4)抑制剂,通过选择性、持续性抑制DPP-4,控制血糖水平。曲格列汀具有良好的安全性和耐受性,曲格列汀每周给药1次便可有效控制血糖水平,改善患者的用药依从性。用于2型糖尿病的治疗。 物理化学性质: CAS号:865759-25-7 常用中文名:曲格列汀 常用英文名:Trelagliptin 分子式:C18H20FN5O2 分子量:357.382 密度:1.4±0.1 g/cm3 沸点:519.0±60.0 °C at 760 mmHg 熔点:N/A 闪点:267.7±32.9 °C 储存条件:-20°C |